Molecular Impact of Mutations in RNA Splicing Factors in Cancer

Overview

Journal Mol Cell

Publisher Cell Press

Specialty Cell Biology

Date 2024 Aug 15

PMID 39146933

Authors

Qian Zhang

Yuxi Ai

Omar Abdel-Wahab

Affiliations

Soon will be listed here.

Abstract

Somatic mutations in genes encoding components of the RNA splicing machinery occur frequently in multiple forms of cancer. The most frequently mutated RNA splicing factors in cancer impact intronic branch site and 3' splice site recognition. These include mutations in the core RNA splicing factor SF3B1 as well as mutations in the U2AF1/2 heterodimeric complex, which recruits the SF3b complex to the 3' splice site. Additionally, mutations in splicing regulatory proteins SRSF2 and RBM10 are frequent in cancer, and there has been a recent suggestion that variant forms of small nuclear RNAs (snRNAs) may contribute to splicing dysregulation in cancer. Here, we describe molecular mechanisms by which mutations in these factors alter splice site recognition and how studies of this process have yielded new insights into cancer pathogenesis and the molecular regulation of splicing. We also discuss data linking mutant RNA splicing factors to RNA metabolism beyond splicing.

Citing Articles

SUGP1 loss is the sole driver of SF3B1 hotspot mutant missplicing in cancer.

Xing P, Bak-Gordon P, Xie J, Zhang J, Liu Z, Manley J bioRxiv. 2025; .

PMID: 40027711 PMC: 11870612. DOI: 10.1101/2025.02.17.638713.

Precursor RNA structural patterns at SF3B1 mutation sensitive cryptic 3' splice sites.

Herbert A, Hatfield A, Randazza A, Miyamoto V, Palmer K, Lackey L bioRxiv. 2025; .

PMID: 40027643 PMC: 11870503. DOI: 10.1101/2025.02.19.638873.

The emerging roles of aberrant alternative splicing in glioma.

Ben Mrid R, El Guendouzi S, Mineo M, El Fatimy R Cell Death Discov. 2025; 11(1):50.

PMID: 39915450 PMC: 11802826. DOI: 10.1038/s41420-025-02323-0.

SF3B1: from core splicing factor to oncogenic driver.

Bak-Gordon P, Manley J RNA. 2025; 31(3):314-332.

PMID: 39773890 PMC: 11874996. DOI: 10.1261/rna.080368.124.

Mutational disparities in colorectal cancers of White Americans, Alabama African Americans, And Oklahoma American Indians.

Yamada H, Rout M, Xu C, ONeill P, Afaq F, Morris K NPJ Precis Oncol. 2024; 8(1):288.

PMID: 39715885 PMC: 11666716. DOI: 10.1038/s41698-024-00782-9.

References

Petermann E, Lan L, Zou L . Sources, resolution and physiological relevance of R-loops and RNA-DNA hybrids. Nat Rev Mol Cell Biol. 2022; 23(8):521-540. DOI: 10.1038/s41580-022-00474-x. View

Ibrahimpasic T, Xu B, Landa I, Dogan S, Middha S, Seshan V . Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of and as Novel Thyroid Cancer Genes Associated with Tumor Virulence. Clin Cancer Res. 2017; 23(19):5970-5980. PMC: 5626586. DOI: 10.1158/1078-0432.CCR-17-1183. View

Inoue D, Polaski J, Taylor J, Castel P, Chen S, Kobayashi S . Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition. Nat Genet. 2021; 53(5):707-718. PMC: 8177065. DOI: 10.1038/s41588-021-00828-9. View

Biancon G, Joshi P, Zimmer J, Hunck T, Gao Y, Lessard M . Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies. Mol Cell. 2022; 82(6):1107-1122.e7. PMC: 8988922. DOI: 10.1016/j.molcel.2022.02.025. View

Yang F, Bian T, Zhan X, Chen Z, Xing Z, Larsen N . Mechanisms of the RNA helicases DDX42 and DDX46 in human U2 snRNP assembly. Nat Commun. 2023; 14(1):897. PMC: 9935549. DOI: 10.1038/s41467-023-36489-x. View

Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R . Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011; 478(7367):64-9. DOI: 10.1038/nature10496. View

Faber Z, Chen X, Gedman A, Boggs K, Cheng J, Ma J . The genomic landscape of core-binding factor acute myeloid leukemias. Nat Genet. 2016; 48(12):1551-1556. PMC: 5508996. DOI: 10.1038/ng.3709. View

Imielinski M, Berger A, Hammerman P, Hernandez B, Pugh T, Hodis E . Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell. 2012; 150(6):1107-20. PMC: 3557932. DOI: 10.1016/j.cell.2012.08.029. View

Cheruiyot A, Li S, Nonavinkere Srivatsan S, Ahmed T, Chen Y, Lemacon D . Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring or Mutations. Cancer Res. 2021; 81(17):4499-4513. PMC: 8416940. DOI: 10.1158/0008-5472.CAN-20-4016. View

10.

Simmler P, Ioannidi E, Mengis T, Marquart K, Asawa S, Van-Lehmann K . Mutant SF3B1 promotes malignancy in PDAC. Elife. 2023; 12. PMC: 10629822. DOI: 10.7554/eLife.80683. View

11.

Graveley B, Maniatis T . Arginine/serine-rich domains of SR proteins can function as activators of pre-mRNA splicing. Mol Cell. 1998; 1(5):765-71. DOI: 10.1016/s1097-2765(00)80076-3. View

12.

GORLIN R, cervenka J, Anderson R, Sauk J, Bevis W . Robin's syndrome. A probably X-linked recessive subvariety exhibiting persistence of left superior vena cava and atrial septal defect. Am J Dis Child. 1970; 119(2):176-8. View

13.

Rahman M, Lin K, Bradley R, Abdel-Wahab O, Krainer A . Recurrent SRSF2 mutations in MDS affect both splicing and NMD. Genes Dev. 2020; 34(5-6):413-427. PMC: 7050488. DOI: 10.1101/gad.332270.119. View

14.

Wilkinson M, Lin P, Plaschka C, Nagai K . Cryo-EM Studies of Pre-mRNA Splicing: From Sample Preparation to Model Visualization. Annu Rev Biophys. 2018; 47:175-199. DOI: 10.1146/annurev-biophys-070317-033410. View

15.

Obeng E, Chappell R, Seiler M, Chen M, Campagna D, Schmidt P . Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation. Cancer Cell. 2016; 30(3):404-417. PMC: 5023069. DOI: 10.1016/j.ccell.2016.08.006. View

16.

Wilkinson M, Charenton C, Nagai K . RNA Splicing by the Spliceosome. Annu Rev Biochem. 2019; 89:359-388. DOI: 10.1146/annurev-biochem-091719-064225. View

17.

Chen L, Chen J, Huang Y, Gu Y, Qiu J, Qian H . The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations. Mol Cell. 2018; 69(3):412-425.e6. PMC: 5957072. DOI: 10.1016/j.molcel.2017.12.029. View

18.

Brooks A, Choi P, de Waal L, Sharifnia T, Imielinski M, Saksena G . A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events. PLoS One. 2014; 9(1):e87361. PMC: 3909098. DOI: 10.1371/journal.pone.0087361. View

19.

Furney S, Pedersen M, Gentien D, Dumont A, Rapinat A, Desjardins L . SF3B1 mutations are associated with alternative splicing in uveal melanoma. Cancer Discov. 2013; 3(10):1122-1129. PMC: 5321577. DOI: 10.1158/2159-8290.CD-13-0330. View

20.

Maji D, Glasser E, Henderson S, Galardi J, Pulvino M, Jenkins J . Representative cancer-associated U2AF2 mutations alter RNA interactions and splicing. J Biol Chem. 2020; 295(50):17148-17157. PMC: 7863893. DOI: 10.1074/jbc.RA120.015339. View